000 | 01541 a2200469 4500 | ||
---|---|---|---|
005 | 20250515072927.0 | ||
264 | 0 | _c20070806 | |
008 | 200708s 0 0 eng d | ||
022 | _a1359-6535 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGelderblom, Huub C | |
245 | 0 | 0 |
_aLow-level HCV viraemia after initial response during antiviral therapy: transcription-mediated amplification predicts treatment failure. _h[electronic resource] |
260 |
_bAntiviral therapy _c2007 |
||
300 |
_a423-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntiviral Agents _xtherapeutic use |
650 | 0 | 4 | _aBiomarkers |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHepacivirus _xgenetics |
650 | 0 | 4 |
_aHepatitis C, Chronic _xdiagnosis |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNucleic Acid Amplification Techniques |
650 | 0 | 4 | _aPolymerase Chain Reaction |
650 | 0 | 4 | _aPredictive Value of Tests |
650 | 0 | 4 |
_aRNA, Viral _xblood |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aSpecies Specificity |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 |
_aViremia _xdiagnosis |
700 | 1 | _aReesink, Henk W | |
700 | 1 | _aBeld, Marcel G H M | |
700 | 1 | _aWeegink, Christine J | |
700 | 1 | _aJansen, Peter L M | |
700 | 1 | _aDijkgraaf, Marcel G W | |
700 | 1 | _aZaaijer, Hans L | |
773 | 0 |
_tAntiviral therapy _gvol. 12 _gno. 3 _gp. 423-7 |
|
999 |
_c17128025 _d17128025 |